The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10087 malaria professionals are enjoying the free benefits of MalariaWorld today

artesunate-amodiaquine (ASAQ)

Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar

September 13, 2012 - 13:22 -- Kabogo Ndegwa
Author(s): 
Fröberg G, Jörnhagen L, Morris U, Shakely D, Msellem MI, Gil JP, Björkman A, Mårtensson A
Reference: 
Malaria Journal 2012, 11:321 (11 September 2012)

MalariaWorldThis is the first observation of a decreased prevalence of pfcrt 76T, pfmdr1 86Y, 184Y and 1246Y in an African setting after several years of extensive ASAQ use as first-line treatment for uncomplicated malaria.

Country: 
Medical Condition: 
Subscribe to RSS - artesunate-amodiaquine (ASAQ)